1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Global Proton Therapy Market: Trends & Opportunities (2013-2018)

  • February 2014
  • 68 pages
  • Daedal Research
Report ID: 2040581

Summary

Table of Contents

Search Inside

Scope of the Report

The report titled “Global Proton Therapy Market: Trends and Opportunities (2013-2018)” analyzes the potential opportunities and significant trends in the global proton therapy market. The report also provides detailed analysis of the global proton therapy market, with data of regional markets such as North America, Europe and Asia. The report also profiles and analyzes the business strategies of the leading companies operating in the segment.

Geographical Coverage

Global
North America
Europe
Asia

Company Profiles

IBA Proton Therapy Inc.
Hitach
Varian Medical System
Mitsubishi Energy and Electrical Corporation

Executive Summary
Proton therapy or proton beam therapy is a highly precise method of radiotherapy. The treatment is suitable for all patients regardless of age and as proton-therapy technology is continuously advancing, features such as rotational gantries, higher energies and larger fields have expanded the treatment's application to potentially any site in the body. IBA is the world leader and market pioneer of proton therapy.

Globally the penetration of proton therapy centers is highest in North America, mainly in the US, followed by Europe and Asia. The US retains the highest number of proton therapy centers and many are in development phase or under construction. Proton therapy technology has also made inroads in different countries as various governments are showing interest in this advanced technology. Proton therapy is still developing in Europe, mainly because of low awareness of this therapy and also because it is comparatively expensive. But as the therapy is getting acceptability because of its effectiveness, and this technology holds immense potential as evident in the growing number of proton centers across the world.

One of the chief arguments against the procedure of proton therapy is its massive cost as it is hugely expensive to set-up and deliver a proton beam therapy center. Further, new technology such as pencil beam scanning is coming up which has the ability to treat the most complex of tumors, while leaving healthy tissue and critical structures untouched. This technology is used with proton therapy and many new proton centers are adapting this technology.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Non-small cell lung cancer (NSCLC) disease forecast and market analysis to 2035

  • $ 22000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Disease Overview Lung cancer is a disease in which the cells in lung tissue grow uncontrollably. More than 80% of lung cancers are non-small cell lung cancers (NSCLC), with the exact proportion depending ...

Renal cell cancer (RCC) disease forecast and market analysis to 2035

  • $ 22000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Disease Overview Renal cell cancer (RCC) is a tumor that originates in the renal cortex, the outer part of the kidney between the renal capsule and the renal medulla. Around 85% of all malignant kidney ...

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

  • $ 6995
  • Industry report
  • May 2017
  • by GBI Research

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline Summary Hematological cance ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.